Diversify Wealth Management LLC Has $2.53 Million Stock Position in STERIS plc $STE

Diversify Wealth Management LLC lifted its stake in STERIS plc (NYSE:STE) by 36.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,914 shares of the medical equipment provider’s stock after acquiring an additional 3,197 shares during the period. Diversify Wealth Management LLC’s holdings in STERIS were worth $2,534,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Board of the Pension Protection Fund bought a new position in shares of STERIS during the 4th quarter worth about $25,000. Activest Wealth Management lifted its stake in shares of STERIS by 423.8% in the fourth quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 89 shares during the period. Measured Wealth Private Client Group LLC bought a new stake in shares of STERIS in the fourth quarter valued at about $28,000. Harbor Investment Advisory LLC lifted its stake in shares of STERIS by 115.4% in the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 60 shares during the period. Finally, Cornerstone Planning Group LLC grew its position in STERIS by 342.3% during the fourth quarter. Cornerstone Planning Group LLC now owns 115 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 89 shares in the last quarter. Institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In related news, VP John Adam Zangerle sold 1,419 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $209.28, for a total transaction of $296,968.32. Following the sale, the vice president owned 35,259 shares of the company’s stock, valued at approximately $7,379,003.52. This trade represents a 3.87% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel A. Carestio sold 3,054 shares of the firm’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $214.64, for a total value of $655,510.56. Following the sale, the chief executive officer directly owned 65,021 shares in the company, valued at approximately $13,956,107.44. This represents a 4.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 7,328 shares of company stock valued at $1,554,051. 1.12% of the stock is currently owned by company insiders.

STERIS Stock Performance

Shares of NYSE:STE opened at $216.84 on Tuesday. STERIS plc has a twelve month low of $195.14 and a twelve month high of $269.44. The firm has a market cap of $21.13 billion, a PE ratio of 27.34 and a beta of 0.92. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.54 and a current ratio of 2.09. The business has a fifty day moving average of $211.31 and a 200-day moving average of $230.02.

STERIS (NYSE:STE) last issued its quarterly earnings results on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.59 billion. STERIS had a net margin of 13.18% and a return on equity of 14.15%. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the business earned $2.74 EPS. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. On average, equities research analysts predict that STERIS plc will post 11.18 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, June 26th. Shareholders of record on Monday, June 8th were paid a $0.63 dividend. The ex-dividend date of this dividend was Monday, June 8th. This represents a $2.52 annualized dividend and a yield of 1.2%. STERIS’s dividend payout ratio is presently 31.78%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on STE. Weiss Ratings cut STERIS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, May 27th. KeyCorp reduced their target price on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a research report on Wednesday, May 13th. Piper Sandler reiterated an “overweight” rating and set a $270.00 price target on shares of STERIS in a research note on Thursday, May 21st. Finally, Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 6th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $278.00.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.